Modulation of Inducible Nitric Oxide Synthase Expression by the Attaching and Effacing Bacterial Pathogen Citrobacter rodentium in Infected Mice

ABSTRACT Citrobacter rodentium belongs to the attaching and effacing family of enteric bacterial pathogens that includes both enteropathogenic and enterohemorrhagic Escherichia coli. These bacteria infect their hosts by colonizing the intestinal mucosal surface and intimately attaching to underlying epithelial cells. The abilities of these pathogens to exploit the cytoskeleton and signaling pathways of host cells are well documented, but their interactions with the host's antimicrobial defenses, such as inducible nitric oxide synthase (iNOS), are poorly understood. To address this issue, we infected mice with C. rodentium and found that iNOS mRNA expression in the colon significantly increased during infection. Immunostaining identified epithelial cells as the major source for immunoreactive iNOS. Finding that nitric oxide (NO) donors were bacteriostatic for C. rodentium in vitro, we examined whether iNOS expression contributed to host defense by infecting iNOS-deficient mice. Loss of iNOS expression caused a small but significant delay in bacterial clearance without affecting tissue pathology. Finally, immunofluorescence staining was used to determine if iNOS expression was localized to infected cells by staining for the C. rodentium virulence factor, translocated intimin receptor (Tir), as well as iNOS. Interestingly, while more than 85% of uninfected epithelial cells expressed iNOS, fewer than 15% of infected (Tir-positive) cells expressed detectable iNOS. These results demonstrate that both iNOS and intestinal epithelial cells play an active role in host defense during C. rodentium infection. However, the selective expression of iNOS by uninfected but not infected cells suggests that this pathogen has developed mechanisms to locally limit its exposure to host-derived NO.

[1]  M. Hensel,et al.  Salmonella Pathogenicity Island 2 Mediates Protection of Intracellular Salmonella from Reactive Nitrogen Intermediates , 2002, The Journal of experimental medicine.

[2]  B. Finlay,et al.  Mice Lacking T and B Lymphocytes Develop Transient Colitis and Crypt Hyperplasia yet Suffer Impaired Bacterial Clearance during Citrobacter rodentium Infection , 2002, Infection and Immunity.

[3]  R. Forsythe,et al.  Lipopolysaccharide-Induced Enterocyte-Derived Nitric Oxide Induces Intestinal Monolayer Permeability in an Autocrine Fashion , 2002, Shock.

[4]  J. Gordon,et al.  Molecular Regulation of Urothelial Renewal and Host Defenses during Infection with Uropathogenic Escherichia coli * 210 , 2002, The Journal of Biological Chemistry.

[5]  S. Clare,et al.  Impaired Resistance and Enhanced Pathology During Infection with a Noninvasive, Attaching-Effacing Enteric Bacterial Pathogen, Citrobacter rodentium, in Mice Lacking IL-12 or IFN-γ , 2002, The Journal of Immunology.

[6]  F. Fang,et al.  The Global Regulator ArcA Controls Resistance to Reactive Nitrogen and Oxygen Intermediates in Salmonella enterica Serovar Enteritidis , 2002, Infection and Immunity.

[7]  J. Rask-Madsen,et al.  Colonic Production of Nitric Oxide Gas in Ulcerative Colitis, Collagenous Colitis and Uninflamed Bowel , 2002, Scandinavian journal of gastroenterology.

[8]  A. Gobert,et al.  Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T. Eisenstein Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule. , 2001, Microbes and infection.

[10]  F. Fang,et al.  Salmonella evasion of the NADPH phagocyte oxidase. , 2001, Microbes and infection.

[11]  P. Hellström,et al.  Rectal nitric oxide assessment in children with Crohn disease and ulcerative colitis. Indicator of ileocaecal and colorectal affection. , 2001, Scandinavian journal of gastroenterology.

[12]  B. Finlay,et al.  Enteropathogenic Escherichia coli Infection Induces Expression of the Early Growth Response Factor by Activating Mitogen-Activated Protein Kinase Cascades in Epithelial Cells , 2001, Infection and Immunity.

[13]  S. Savkovic,et al.  EPEC-activated ERK1/2 participate in inflammatory response but not tight junction barrier disruption. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[14]  B. Finlay,et al.  Locus of Enterocyte Effacement from Citrobacter rodentium: Sequence Analysis and Evidence for Horizontal Transfer among Attaching and Effacing Pathogens , 2001, Infection and Immunity.

[15]  D. Holden,et al.  Macrophage Nitric Oxide Synthase Associates with Cortical Actin but Is Not Recruited to Phagosomes , 2001, Infection and Immunity.

[16]  N. Sato,et al.  Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[17]  D. Philpott,et al.  Innate immune responses of epithelial cells following infection with bacterial pathogens. , 2001, Current opinion in immunology.

[18]  N. Brot,et al.  Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Gail Hecht Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VII. Enteropathogenic Escherichia coli: physiological alterations from an extracellular position. , 2001, American Journal of Physiology - Gastrointestinal and Liver Physiology.

[20]  S. Clare,et al.  Understanding mucosal responsiveness: lessons from enteric bacterial pathogens. , 2001, Seminars in immunology.

[21]  N. Tangthawornchaikul,et al.  Burkholderia pseudomallei Interferes with Inducible Nitric Oxide Synthase (iNOS) Production: A Possible Mechanism of Evading Macrophage Killing , 2001, Microbiology and immunology.

[22]  E. Boedeker,et al.  Complete Nucleotide Sequence and Analysis of the Locus of Enterocyte Effacement from Rabbit Diarrheagenic Escherichia coli RDEC-1 , 2001, Infection and Immunity.

[23]  B. Finlay,et al.  Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3‐kinase‐dependent pathways , 2001, The EMBO journal.

[24]  S. Dahan,et al.  Implication of Mitogen-Activated Protein Kinases in T84 Cell Responses to Enteropathogenic Escherichia coli Infection , 2001, Infection and Immunity.

[25]  B. Christensson,et al.  Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator , 2001, Nature Medicine.

[26]  A. Steigerwalt,et al.  Citrobacter rodentium, the Causative Agent of Transmissible Murine Colonic Hyperplasia, Exhibits Clonality: Synonymy of C. rodentium and Mouse-PathogenicEscherichia coli , 2000, Journal of Clinical Microbiology.

[27]  B. Finlay,et al.  Human Response to Escherichia coliO157:H7 Infection: Antibodies to Secreted Virulence Factors , 2000, Infection and Immunity.

[28]  C. Nathan,et al.  Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Finlay,et al.  Exploitation of host cells by enteropathogenic Escherichia coli. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Moilanen,et al.  Regulation of nitric oxide production in cultured human T84 intestinal epithelial cells by nuclear factor‐κB‐dependent induction of inducible nitric oxide synthase after exposure to bacterial endotoxin , 2000 .

[31]  P. Kubes Inducible nitric oxide synthase: a little bit of good in all of us , 2000, Gut.

[32]  B. Finlay,et al.  Role of EspB in Experimental Human EnteropathogenicEscherichia coli Infection , 2000, Infection and Immunity.

[33]  M. Kagnoff,et al.  Analysis by High Density cDNA Arrays of Altered Gene Expression in Human Intestinal Epithelial Cells in Response to Infection with the Invasive Enteric BacteriaSalmonella * , 2000, The Journal of Biological Chemistry.

[34]  B. P. McNamara,et al.  A Large Toxin from Pathogenic Escherichia coli Strains That Inhibits Lymphocyte Activation , 2000, Infection and Immunity.

[35]  B. Finlay,et al.  Enteropathogenic Escherichia coli (EPEC) attachment to epithelial cells: exploiting the host cell cytoskeleton from the outside , 2000, Cellular microbiology.

[36]  B. Zabel,et al.  Citrobacter rodentium espB Is Necessary for Signal Transduction and for Infection of Laboratory Mice , 1999, Infection and Immunity.

[37]  I. Connerton,et al.  Role of bacterial intimin in colonic hyperplasia and inflammation. , 1999, Science.

[38]  W. Goldman,et al.  Signalling and cellular specificity of airway nitric oxide production in pertussis , 1999, Cellular microbiology.

[39]  S. Meltzer,et al.  Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. , 1999, Gastroenterology.

[40]  G. Dougan,et al.  Citrobacter rodentium Infection in Mice Elicits a Mucosal Th1 Cytokine Response and Lesions Similar to Those in Murine Inflammatory Bowel Disease , 1999, Infection and Immunity.

[41]  J. Wallace,et al.  Prolonged colonic epithelial hyporesponsiveness after colitis: role of inducible nitric oxide synthase. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[42]  W. MacNaughton,et al.  Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis. , 1998, The American journal of physiology.

[43]  G. Dougan,et al.  Enteropathogenic and enterohaemorrhagic Escherichia coli : more subversive elements , 1998, Molecular microbiology.

[44]  R. Hegele,et al.  Two Enteropathogenic Escherichia coli Type III Secreted Proteins, EspA and EspB, Are Virulence Factors , 1998, The Journal of experimental medicine.

[45]  Jung Mogg Kim,et al.  Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[46]  J. Westwick,et al.  Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines , 1998, Gut.

[47]  A. Rudensky,et al.  Medullary Thymic Epithelium: A Mosaic of Epithelial “Self”? , 1998, The Journal of experimental medicine.

[48]  B. Finlay,et al.  Enteropathogenic E. coli (EPEC) Transfers Its Receptor for Intimate Adherence into Mammalian Cells , 1997, Cell.

[49]  S. Savkovic,et al.  Activation of NF-κB in intestinal epithelial cells by enteropathogenic Escherichia coli. , 1997, American journal of physiology. Cell physiology.

[50]  S. Savkovic,et al.  Attachment of a noninvasive enteric pathogen, enteropathogenic Escherichia coli, to cultured human intestinal epithelial monolayers induces transmigration of neutrophils , 1996, Infection and immunity.

[51]  J. Abraham,et al.  Products of enteropathogenic E. coli inhibit lymphokine production by gastrointestinal lymphocytes. , 1996, The American journal of physiology.

[52]  J. Beesley,et al.  Expression of nitric oxide synthase in ulcerative colitis , 1996, European journal of clinical investigation.

[53]  I. Charles,et al.  Altered immune responses in mice lacking inducible nitric oxide synthase , 1995, Nature.

[54]  F. Patricio,et al.  [Morphometrics of the small intestine in children with diarrhea due to classical enteropathogenic Escherichia coli and to environmental asymptomatic enteropathy]. , 1995, Revista da Associacao Medica Brasileira.

[55]  R. Robins-Browne,et al.  Adherence characteristics of attaching and effacing strains of Escherichia coli from rabbits , 1994, Infection and immunity.

[56]  S. Falkow,et al.  The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia , 1993, Infection and immunity.

[57]  J. Walker-Smith,et al.  Enteropathogenic Escherichia coli and life threatening chronic diarrhoea. , 1991, Gut.

[58]  L. Trabulsi,et al.  Protracted Diarrhea: The Importance of the Enteropathogenic E. coli (EPEC) Strains and Salmonella in Its Genesis , 1989, Journal of pediatric gastroenterology and nutrition.

[59]  G. L. Coleman,et al.  Transmissible Murine Colonic Hyperplasia , 1978, Veterinary pathology.

[60]  D. Kopecko,et al.  Breaching the mucosal barrier by stealth: an emerging pathogenic mechanism for enteroadherent bacterial pathogens. , 2001, The Journal of clinical investigation.

[61]  A. Fruth,et al.  Enterohemorrhagic Escherichia coli. , 2001, Contributions to microbiology.

[62]  B. Finlay,et al.  Gut feelings: enteropathogenic E. coli (EPEC) interactions with the host. , 2000, Annual review of cell and developmental biology.

[63]  E. Moilanen,et al.  Regulation of nitric oxide production in cultured human T84 intestinal epithelial cells by nuclear factor-kappa B-dependent induction of inducible nitric oxide synthase after exposure to bacterial endotoxin. , 2000, Alimentary pharmacology & therapeutics.

[64]  B. Finlay,et al.  Enteropathogenic Escherichia coli inhibits phagocytosis. , 1999, Infection and immunity.

[65]  B. China,et al.  The locus for enterocyte effacement (LEE) of enteropathogenic Escherichia coli (EPEC) from dogs and cats. , 1999, Advances in experimental medicine and biology.

[66]  C. Szabó,et al.  Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. , 1998, Gastroenterology.

[67]  D. Schauer Murine Colonic Hyperplasia , 1994 .

[68]  D. Portnoy,et al.  Molecular Genetics of Bacterial Pathogenesis , 1994 .